(Q70766287)

English

Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

scientific article published on 01 July 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

based on heuristic

inferred from title

author name string

I G Ron

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M J Inbar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M Gutman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

O Merimsky

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

S Chaitchik

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 July 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

61-66

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01516943

0 references

Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in the treatment of malignant melanoma. A review of recent trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DTIC therapy in metastatic malignant melanoma: a simplified dose schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in combination with vinblastine in advanced malignant melanoma. A phase I-II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional and systemic strategies for metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in the treatment of malignant melanoma. Results of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTIC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in the treatment of human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8513453

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01516943

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513453%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70766287&oldid=1984422295"